National guidance from NICE and the RCOG stresses prospective symptom recording, history-taking, and differential diagnosis for PMS and PMDD. However, NHS datasets do not reliably distinguish PMDD, constraining population-level visibility and commissioning.
Policy context
The Women’s Health Strategy identifies menstrual health and data improvement as priorities, with commitments to education, pathways, and research via NIHR. Royal Colleges are enhancing training, yet regional variation persists. Digital tools and interoperability with NHS systems remain underdeveloped.
Medication and masking
Prescribing across specialties without integrated cycle review can obscure diagnostic patterns. Governance frameworks should promote holistic medication reconciliation and documentation standards. This aligns with broader patient safety themes around continuity and recognition of fluctuating symptoms.
Perinatal links
Guidance encourages comprehensive history, but embedding in routine assessments varies. Fragmentation between services echoes wider findings in safety investigations.
Risk and claims themes
While specific PMS/PMDD litigation data is not prominently isolated in NHS Resolution reports, broader patterns of delayed recognition of cyclical symptoms, repeated consultations, and communication gaps appear in claims involving mood and functional impairment. Emphasis remains on process, documentation, and continuity rather than individual error.
Improvement priorities
- Standardised diagnostic coding for PMDD.
- Integrated digital tracking.
- Defined inter-specialty pathways.
- Diverse research cohorts.
- Co-designed resources and audit of menstrual history-taking in relevant presentations.
These align with strategy goals and could reduce variation and delay.
Questions for governance
- How can data systems better capture menstrual-linked conditions?
- What metrics support equitable access and timely assessment?
- How are training and pathway compliance monitored?
Disclaimer
This article is for general information and discussion only. It is not medical or legal advice, nor a substitute for professional advice. To contribute evidence, ideas, or corrections, please email womenshealthproject@outlook.com. Please do not share personal data when emailing. Individual cases cannot be reviewed.
This project does not offer any form of legal service and cannot assist with complaints, claims or individual advocacy. This platform is independent and not affiliated with any law firm, regulator, inquiry or clinical body.
© 2026 Women’s Health Inquiry Project (WHIP). This article includes original analysis of material from publicly available national sources. It may not be reproduced without permission.
References
- Women’s Health Strategy for England (renewed).
- RCOG and NICE guidance.
- NHS Resolution annual reports (contextual).